Franziska Wachter: Clinical Trials

1 trial sponsored by Franziska Wachter, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1

Follow Franziska Wachter: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
Decitabine, Filgrastim - Acute Myeloid Leukemia, Myelodysplastic Syndromes
Phase 2Active not recruitingFranziska Wachter292023-04-192026-08-20

Conditions studied

Congenital Bone Marrow Failure Syndromes (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Myelodysplastic Syndromes (1)

Interventions

Decitabine (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)

Countries

United States (1)